Centessa Pharmaceuticals (CNTA) Other Non Operating Income (2020 - 2026)
Centessa Pharmaceuticals (CNTA) reported Other Non Operating Income of -$1.0 million for Q1 2026, down 199.9% year-over-year from $1.0 million in Q1 2025, and up 63.5% on a QoQ basis from -$2.8 million in Q4 2025.
Centessa Pharmaceuticals (CNTA) has 7 years of Other Non Operating Income data on file, last reported at -$1.0 million in Q1 2026.
- Quarterly Other Non Operating Income fell 199.9% year-over-year to -$1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.1 million (down 334.13% YoY) and the FY2024 annual result came in at -$1.7 million, changed N/A from the prior year.
- Other Non Operating Income grew to -$1.0 million in Q1 2026 per CNTA's latest filing, from -$2.8 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $5.4 million in Q2 2022 and bottomed at -$4.0 million in Q4 2024.
- The 5-year median for Other Non Operating Income is -$1.0 million (2026), against an average of -$21764.7.
- Peak annual rise in Other Non Operating Income reached 6600.0% in 2023, while the deepest fall reached 786.73% in 2023.
- Tracing CNTA's Other Non Operating Income over 5 years: stood at -$70000.0 in 2022, then jumped by 6600.0% to $4.6 million in 2023, then sank by 187.21% to -$4.0 million in 2024, then rose by 29.23% to -$2.8 million in 2025, then surged by 63.5% to -$1.0 million in 2026.
- Per Business Quant, the three latest CNTA Other Non Operating Income figures stand at -$1.0 million (Q1 2026), -$2.8 million (Q4 2025), and -$1.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Centessa Pharmaceuticals | 6.12 Bn | 6.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.03 Mn |
| Dec 31, 2025 | -2.81 Mn |
| Sep 30, 2025 | -1.81 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | -3.97 Mn |
| Sep 30, 2024 | 3.66 Mn |
| Jun 30, 2024 | 154,000.00 |
| Mar 31, 2024 | -1.54 Mn |
| Dec 31, 2023 | 4.55 Mn |
| Sep 30, 2023 | -1.68 Mn |
| Jun 30, 2023 | -1.53 Mn |
| Mar 31, 2023 | -1.35 Mn |
| Dec 31, 2022 | -70,000.00 |
| Sep 30, 2022 | -3.14 Mn |
| Jun 30, 2022 | 5.36 Mn |
| Mar 31, 2022 | 196,000.00 |
| Dec 31, 2021 | 235,000.00 |
| Sep 30, 2021 | -1.91 Mn |
| Jun 30, 2021 | -191,000.00 |
| Mar 31, 2021 | -2.51 Mn |
| Dec 31, 2020 | -184,000.00 |
| Sep 30, 2020 | 6,000.00 |
| Jun 30, 2020 | -10,000.00 |